• Like
  • Comment
  • Favorite

Shanghai Henlius Biotech Inc - Co's New Drug Application of Innovative Small Molecular Hlx99 ("Hlx99") Was Approved by U.S. FDA

THOMSON REUTERS02-10

Shanghai Henlius Biotech Inc - Co's New Drug Application of Innovative Small Molecular Hlx99 ("Hlx99") Was Approved by U.S. FDA

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
errorbox banner

抱歉,当前请求异常(-1)

7x24

  • 22:58

    Li-S Energy Ltd - Collaboration With Kea Aerospace to Power High Altitude Uavs

  • 22:56

    Eurogroup Laminations Spa - Consolidated Revenues for 2024 Amounted to EUR 869.4 Mln

  • 22:56

    Eurogroup Laminations Spa - Adjusted Ebitda for 2024 Stood at EUR 116 Mln

  • 22:56

    Eurogroup Laminations Spa - Group Revenues Expected to Grow With a Cagr of 10%-15% Over 2025-2028

  • 22:56

    Eurogroup Laminations Spa - Proposed Dividend of EUR 0.042 per Share

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial